Aeolus Pharmaceuticals Inc. (AOLS) Stock Quote

Detailed Quote for Aeolus Pharmaceuticals Inc. (AOLS) 
$ 0.35   0.01 (+2.94%) Volume: 19.25 k 1:04 PM EST Feb 10, 2012
Today 5d 1m 3m 1y more
Last Price
0.35
Change $
0.01
Change %
2.94%
Tick
N/A
Bid
0.20
Bid Size
5,000
Ask
0.74
Ask Size
2,500
Open
0.35
High
0.35
Low
0.34
Prev Close
0.34
Last Trade
2/10/12
Volume
19.25 k
52 Wk Hi
1.10
52 Wk Low
0.30
Market Cap
21.16 m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
60,470,718
EPS (TTM)
N/A
PE Ratio
N/A
Exchange
OTCBB
News and Media for Aeolus Pharmaceuticals Inc.  (AOLS) 
Sector News | Topic News
News for AOLS
Wed, Feb 08, 2012
2:38 PM Aeolus' AEOL 10150 Protects Lung Tissue From Radiation by Modulating PTEN Levels, Reducing Oxidative Stress and Apoptosis - Marketwire
Tue, Feb 07, 2012
6:00 AM Positive Data on AEOL 11207 in Pre-Clinical Epilepsy Model Published in the Journal of Neurobiology of Disease - Marketwire
Tue, Jan 17, 2012
6:58 AM Aeolus to Present at the Noble Financial Capital Markets' 8th Annual Equity Conference - Marketwire
Tue, Dec 27, 2011
7:12 PM Aeolus Pharmaceuticals Announces Fiscal Year 2011 Results - Marketwire
Wed, Dec 07, 2011
11:18 AM Aeolus to Present at the 22nd Annual Oppenheimer Healthcare Conference - Marketwire
Wed, Nov 09, 2011
9:05 AM Aeolus to Present at the Lazard Capital Markets 8th Annual Healthcare Conference - Marketwire
Tue, Nov 01, 2011
8:00 AM Aeolus Pharmaceuticals Announces Positive Results From Study of AEOL 10150 and Neupogen(R) as Combination Therapy for Treatment of Acute Radiation Syndrome - Marketwire
Mon, Oct 24, 2011
10:02 AM Aeolus to Present at the 10th Annual BIO Investor Forum - Marketwire
7:02 AM Aeolus Pharmaceuticals Announces NIH Counteract Grant Award to Develop AEOL 10150 as a Treatment Against Nerve Agent Exposure - Marketwire
Mon, Oct 10, 2011
11:56 AM Aeolus Pharmaceuticals Announces $12.7 Million NIH Counteract Grant Award to Continue Development of AEOL 10150 as a Treatment Against Chlorine and Sulfur Mustard Gas Exposure - Marketwire
Wed, Oct 05, 2011
11:28 AM Roth Capital Initiates Equity Research Analyst Coverage on Aeolus - Marketwire
Fri, Sep 23, 2011
1:27 PM Aeolus Pharmaceuticals Files Request for Orphan Drug Designation of AEOL 10150 for Mitigation, and/or Treatment of Delayed Effects of Acute Radiation Exposure of the Lung - Marketwire
Tue, Sep 06, 2011
5:42 PM Aeolus to Present at Stifel Nicolaus' Annual Healthcare Conference - Marketwire
Thu, Sep 01, 2011
11:19 AM Aeolus Pharmaceuticals' Announces Presentation of AEOL10150 Data at the 14th International Congress of Radiation Research - Marketwire
Mon, Aug 29, 2011
2:34 PM Ladenburg Thalmann Initiates Equity Research Analyst Coverage on Aeolus - Marketwire
Thu, May 26, 2011
7:33 PM Noble Financial Initiates Equity Research Analyst Coverage on Aeolus - Marketwire
More News for AOLS >>

Tags for Aeolus Pharmaceuticals Inc.

Research stocks or mutual funds related to Aeolus Pharmaceuticals Inc. by keywords or tags. Find companies that have a similar focus to AOLS. The keywords below have been associated to AOLS by either user submission or electronic means.

Drugs Healthcare Common Stock Pharmaceutical Preparation Manufacturing (325412) Pharmaceutical Preparations (2834)